- The pipeline guide covers pipeline products based on several stages of development
ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products
which comprise, product description, descriptive licensing and collaboration details,
R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Juvenile Macular
Degeneration (Ophthalmology) therapeutics and enlists all their major and minor
projects.
- The pipeline guide evaluates Juvenile Macular Degeneration (Ophthalmology)
therapeutics based on mechanism of action (MoA), drug target, route of
administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Juvenile
Macular Degeneration (Ophthalmology)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to
formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create
effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development
for Juvenile Macular Degeneration (Ophthalmology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most
promising pipeline therapeutics.